Russell Investments Group Ltd. Raises Stake in Guardian Pharmacy Services, Inc. $GRDN

Key Points

• Russell Investments Group Ltd. has increased its stake in Guardian Pharmacy Services by 23.4%, owning 90,401 shares valued at $1.92 million.
• Several other institutional investors have also recently adjusted their positions, with Wells Fargo & Company MN increasing its stake by a significant 353.7% in the fourth quarter.
• Wall Street analysts have rated Guardian Pharmacy Services with a consensus rating of "Buy" and a price target averaging $25.67.

Russell Investments Group Ltd. raised its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 23.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 90,401 shares of the company's stock after acquiring an additional 17,160 shares during the period. Russell Investments Group Ltd. owned approximately 0.14% of Guardian Pharmacy Services worth $1,922,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. GAMMA Investing LLC acquired a new position in Guardian Pharmacy Services in the 1st quarter worth $170,000. BNP Paribas Financial Markets bought a new position in shares of Guardian Pharmacy Services during the fourth quarter worth approximately $37,000. JPMorgan Chase & Co. bought a new position in shares of Guardian Pharmacy Services during the fourth quarter worth approximately $77,000. Meeder Asset Management Inc. acquired a new stake in shares of Guardian Pharmacy Services during the 1st quarter worth approximately $88,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth approximately $98,000.

Guardian Pharmacy Services Trading Up 0.5%

Shares of NYSE:GRDN traded up $0.13 on Friday, hitting $26.28. The company had a trading volume of 373,775 shares, compared to its average volume of 252,519. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $26.91. The firm's 50-day simple moving average is $21.91 and its two-hundred day simple moving average is $21.76.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a report on Sunday, August 17th. Truist Financial reissued a "buy" rating and set a $28.00 target price (up from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th. Finally, Raymond James Financial set a $28.00 target price on shares of Guardian Pharmacy Services and gave the company an "outperform" rating in a research note on Wednesday, May 14th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $25.67.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.